Omalizumab in the treatment of eosinophilic granulomatosis with polyangiitis (EGPA): single-center experience in 18 cases

The American College of Rheumatology 1990 criteria for the classification of churg‐strauss syndrome (allergic granulomatosis and angiitis)

Alfonse T. Masi, Gene G. Hunder, J. T. Lie et al. · Arthritis & Rheumatism · 1990 · 2.2K citations

Benefits of omalizumab as add‐on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE

Marc Humbert, Richard Beasley, Jon G. Ayres et al. · Allergy · 2004 · 1.1K citations · Full text

Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis

Michael E. Wechsler, Praveen Akuthota, David Jayne et al. · New England Journal of Medicine · 2017 · 995 citations · Full text

Effects of Treatment with Anti-immunoglobulin E Antibody Omalizumab on Airway Inflammation in Allergic Asthma

Ratko Djukanović, Susan J. Wilson, Monica Kraft et al. · American Journal of Respiratory and Critical Care Medicine · 2004 · 646 citations

Asthma, Inflammatory Lung Disease, Lung Inflammation +16

Overview of the 2012 revised International Chapel Hill Consensus Conference nomenclature of vasculitides

J. Charles Jennette · Clinical and Experimental Nephrology · 2013 · 596 citations · Full text

Dermatology, Medicine, Pathology +1